Moustapha A, Andreu P, Gonzalvez F, Fradin D, Tissier J, Diolez P
J Biol Methods. 2025; 11(4):e99010040.
PMID: 39839094
PMC: 11744068.
DOI: 10.14440/jbm.2024.0055.
Jin X, Chen Z, Yu D, Jiang Q, Chen Z, Yan B
Bioinformatics. 2024; 41(1).
PMID: 39585721
PMC: 11681936.
DOI: 10.1093/bioinformatics/btae708.
Eyitayo A, Boudier-Lemosquet A, Chaignepain S, Priault M, Manon S
Biomolecules. 2023; 13(6).
PMID: 37371456
PMC: 10296133.
DOI: 10.3390/biom13060876.
Shagufta , Ahmad I
RSC Med Chem. 2023; 14(2):218-238.
PMID: 36846377
PMC: 9945856.
DOI: 10.1039/d2md00356b.
Mu Q, Zhang Y, Cheng Q, Huang H, Huang C, Tang L
Ann Transl Med. 2022; 10(14):806.
PMID: 35965833
PMC: 9372698.
DOI: 10.21037/atm-22-3136.
Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review.
Szczepanski J, Tuszewska H, Trotsko N
Molecules. 2022; 27(12).
PMID: 35744873
PMC: 9231410.
DOI: 10.3390/molecules27123750.
Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
Bourafai-Aziez A, Benabderrahmane M, Paysant H, Weiswald L, Poulain L, Carlier L
Drug Des Devel Ther. 2021; 15:5035-5059.
PMID: 34949914
PMC: 8688747.
DOI: 10.2147/DDDT.S323077.
BH3-mimetics: recent developments in cancer therapy.
Townsend P, Kozhevnikova M, Cexus O, Zamyatnin Jr A, Soond S
J Exp Clin Cancer Res. 2021; 40(1):355.
PMID: 34753495
PMC: 8576916.
DOI: 10.1186/s13046-021-02157-5.
B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.
Alam M, Ali S, Mohammad T, Hasan G, Yadav D, Hassan M
Int J Mol Sci. 2021; 22(19).
PMID: 34638779
PMC: 8509036.
DOI: 10.3390/ijms221910442.
Computational Modeling as a Tool to Investigate PPI: From Drug Design to Tissue Engineering.
Perez J, Perez R, Perez A
Front Mol Biosci. 2021; 8:681617.
PMID: 34095231
PMC: 8173110.
DOI: 10.3389/fmolb.2021.681617.
Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein.
do Carmo A, Bettanin F, Oliveira Almeida M, Pantaleao S, Rodrigues T, Homem-de-Mello P
Front Chem. 2020; 8:235.
PMID: 32309275
PMC: 7145989.
DOI: 10.3389/fchem.2020.00235.
2-(2-Methoxyphenyl)-3-((Piperidin-1-yl)ethyl)thiazolidin-4-One-Loaded Polymeric Nanocapsules: In Vitro Antiglioma Activity and In Vivo Toxicity Evaluation.
da Silveira E, Ferreira L, Gehrcke M, Cruz L, Pedra N, Ramos P
Cell Mol Neurobiol. 2019; 39(6):783-797.
PMID: 31115733
PMC: 11462846.
DOI: 10.1007/s10571-019-00678-4.
ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca -signalling dysregulation or toxicity in pancreatic acinar cells.
Jakubowska M, Kerkhofs M, Martines C, Efremov D, Gerasimenko J, Gerasimenko O
Br J Pharmacol. 2018; 176(22):4402-4415.
PMID: 30266036
PMC: 6887725.
DOI: 10.1111/bph.14505.
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.
Ramsey H, Fischer M, Lee T, Gorska A, Arrate M, Fuller L
Cancer Discov. 2018; 8(12):1566-1581.
PMID: 30185627
PMC: 6279595.
DOI: 10.1158/2159-8290.CD-18-0140.
DP1 receptor signaling prevents the onset of intrinsic apoptosis in eosinophils and functions as a transcriptional modulator.
Peinhaupt M, Roula D, Theiler A, Sedej M, Schicho R, Marsche G
J Leukoc Biol. 2018; 104(1):159-171.
PMID: 29607536
PMC: 6032830.
DOI: 10.1002/JLB.3MA1017-404R.
Synthesis and anticancer activity of novel quinazolinone-based rhodanines.
El-Sayed S, Metwally K, El-Shanawani A, Abdel-Aziz L, Pratsinis H, Kletsas D
Chem Cent J. 2017; 11(1):102.
PMID: 29086906
PMC: 5640562.
DOI: 10.1186/s13065-017-0333-x.
Inhibition of yeast-to-filamentous growth transitions in Candida albicans by a small molecule inducer of mammalian apoptosis.
Goffena J, Toenjes K, Butler D
Yeast. 2017; 35(3):291-298.
PMID: 29048745
PMC: 5837920.
DOI: 10.1002/yea.3287.
Microenvironmental agonists generate phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL.
Jayappa K, Portell C, Gordon V, Capaldo B, Bekiranov S, Axelrod M
Blood Adv. 2017; 1(14):933-946.
PMID: 29034364
PMC: 5637393.
DOI: 10.1182/bloodadvances.2016004176.
5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.
Kaminskyy D, Kryshchyshyn A, Lesyk R
Eur J Med Chem. 2017; 140:542-594.
PMID: 28987611
PMC: 7111298.
DOI: 10.1016/j.ejmech.2017.09.031.
On BH3 Mimetics and Ca Signaling.
Ferdek P, Jakubowska M
Drug Dev Res. 2017; 78(6):313-318.
PMID: 28804913
PMC: 5601233.
DOI: 10.1002/ddr.21405.